Association between Arterial Stiffness, Carbamylation, and Mortality in Patients Undergoing Coronary Angiography with No or Mild Chronic Kidney Disease
C-Alb may be a valuable biomarker for assessing CV risk and improving mortality prediction even in patients with no or mild CKD. The findings support the notion of a crosslink between carbamylation, inflammation, atherosclerosis, and mortality. While these results are promising, further research is needed to fully elucidate the role of C-Alb in CV disease progression and risk stratification.
Authors
- Winfried März (ORCID: https://orcid.org/0000-0001-6083-8946)
- Niklas Ayasse (ORCID: https://orcid.org/0009-0005-3436-5969)
- Anders Hayden Berg (ORCID: https://orcid.org/0000-0002-5736-0686)
- Babak Yazdani (ORCID: https://orcid.org/0000-0001-9222-8958)
- Ksenija Stach (ORCID: https://orcid.org/0000-0002-9151-7659)
- Faeq Husain‐Syed (ORCID: https://orcid.org/0000-0001-6742-5052)
- Marcus E. Kleber (ORCID: https://orcid.org/0000-0003-0663-7275)
- Clara Daschner (ORCID: https://orcid.org/0009-0007-0388-3098)
- Bernhard Krämer
- Goekhan Yuecel
Institutions
- Cedars-Sinai Medical Center (US)
- Justus-Liebig-Universität Gießen (DE)
- Medical University of Graz (AT)
- Heidelberg University (DE)
- Universitätsklinikum Gießen und Marburg (DE)
- University Hospital Heidelberg (DE)
- Synlab (Germany) (DE)
- University Medical Centre Mannheim (DE)
Publication Details
- Journal
- Cardiorenal Medicine
- Published
- 2024-12-19
- DOI
- https://doi.org/10.1159/000543143
- Citations
- 3
- Primary Topic
- Cardiovascular Health and Disease Prevention
- Type
- article
- Field-Weighted Citation Impact
- 1.21